D

Day One Biopharmaceuticals

122 employees

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pediatric Oncology
Hematology
Neuro-Oncology
Oncology
Pharmaceutical
MAPK
Health Care
Childhood Cancer
Glioma
Drug Development
Biopharma
Translational Medicine
Targeted Therapies
Cancer

Date founded

2018

Funding rounds raised

Total raised

$130M

from 6 investors over 6 rounds

D

Day One Biopharmaceuticals raised $130M on February 10, 2021

Investors: Canaan, RA Capital Management, L.P., Viking Global Investors, Atlas Venture, Perceptive Advisors and T. Rowe Price

FAQ